Table 1. Indications for inhaler/nebuliser prescribing
COPD
24 (54.5%)
Asthma
7 (15.9%)
Asthma/COPD
1 (2.3%)
Cystic fibrosis
5 (11.4%)
Bronchiectasis
3 (6.8%)
Asthma/Bronchiectasis
4 (9.1%)